435 related articles for article (PubMed ID: 36465909)
1. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
[TBL] [Abstract][Full Text] [Related]
2. Association of N6-methyladenosine readers' genes variation and expression level with pulmonary tuberculosis.
Li HM; Tang F; Wang LJ; Huang Q; Pan HF; Zhang TP
Front Public Health; 2022; 10():925303. PubMed ID: 36072379
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma.
Yu Y; Liang C; Tang Q; Shi Y; Shen L
Gene; 2024 Feb; 894():147989. PubMed ID: 37972699
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.
Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S
BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014
[TBL] [Abstract][Full Text] [Related]
5. The effect of N6-methyladenosine (m6A) factors on the development of acute respiratory distress syndrome in the mouse model.
Fei L; Sun G; Sun J; Wu D
Bioengineered; 2022 Mar; 13(3):7622-7634. PubMed ID: 35263199
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
[TBL] [Abstract][Full Text] [Related]
7. Decreased
Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer.
Wu Q; Xie X; Huang Y; Meng S; Li Y; Wang H; Hu Y
J Cancer; 2021; 12(3):682-692. PubMed ID: 33403026
[TBL] [Abstract][Full Text] [Related]
9. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases.
Zhang B; Jiang H; Dong Z; Sun A; Ge J
Genes Dis; 2021 Nov; 8(6):746-758. PubMed ID: 34522705
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
[TBL] [Abstract][Full Text] [Related]
11. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
12. The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus.
Luo Q; Rao J; Zhang L; Fu B; Guo Y; Huang Z; Li J
Mol Genet Genomic Med; 2020 Sep; 8(9):e1298. PubMed ID: 32583611
[TBL] [Abstract][Full Text] [Related]
13. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
14. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic, progressive and prognostic performance of m
Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y
Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949
[No Abstract] [Full Text] [Related]
16. Increased METTL3 expression and m
Ma J; Wang X; Yang X; Wang X; Tan T; Fang H; Zhong Y; Zhang Q
BMC Ophthalmol; 2023 Jun; 23(1):252. PubMed ID: 37277716
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272
[TBL] [Abstract][Full Text] [Related]
18. Decreased Peripheral Blood
Luo Q; Fu B; Zhang L; Guo Y; Huang Z; Li J
Dis Markers; 2020; 2020():8193895. PubMed ID: 32685056
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
Front Oncol; 2020; 10():718. PubMed ID: 32547941
[TBL] [Abstract][Full Text] [Related]
20. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.
Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ
Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
